[HTML][HTML] COVID-19 therapeutic options under investigation
M Kaddoura, M AlIbrahim, G Hijazi… - Frontiers in …, 2020 - frontiersin.org
Since its emergence in China in December 2019, COVID-19 has quickly spread around the
globe causing a pandemic. Vaccination or the development of herd immunity seems the only …
globe causing a pandemic. Vaccination or the development of herd immunity seems the only …
[HTML][HTML] An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics
D Wang, Z Li, Y Liu - Journal of infection and public health, 2020 - Elsevier
Since a novel coronavirus pneumonia outbreak in late December 2019, coronavirus disease-
19 (COVID-19) epidemic has gradually spread worldwide, becoming a major public health …
19 (COVID-19) epidemic has gradually spread worldwide, becoming a major public health …
Current pharmacological treatments for SARS-COV-2: A narrative review
G Nittari, G Pallotta, F Amenta, SK Tayebati - European Journal of …, 2020 - Elsevier
The novel coronavirus, later identified as SARS-CoV-2, originating from Wuhan in China in
November 2019, quickly spread around the world becoming a pandemic. Despite the …
November 2019, quickly spread around the world becoming a pandemic. Despite the …
Review of registered clinical trials for the treatment of COVID‐19
Abstract Coronavirus disease 2019 (COVID‐19) is a viral disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2). The disease was first reported in …
respiratory syndrome coronavirus 2 (SARS‐CoV‐2). The disease was first reported in …
[HTML][HTML] COVID-19: The immune responses and clinical therapy candidates
The pandemic of coronavirus disease 2019 (COVID-19), with rising numbers of patients
worldwide, presents an urgent need for effective treatments. To date, there are no therapies …
worldwide, presents an urgent need for effective treatments. To date, there are no therapies …
[HTML][HTML] Potential anti-SARS-CoV-2 therapeutics that target the post-entry stages of the viral life cycle: A comprehensive review
RA Al-Horani, S Kar - Viruses, 2020 - mdpi.com
The coronavirus disease-2019 (COVID-19) pandemic continues to challenge health care
systems around the world. Scientists and pharmaceutical companies have promptly …
systems around the world. Scientists and pharmaceutical companies have promptly …
[HTML][HTML] Approaches towards fighting the COVID‑19 pandemic
Abstract The coronavirus disease 2019 (COVID‑19) outbreak, which has caused> 46
millions confirmed infections and> 1.2 million coronavirus related deaths, is one of the most …
millions confirmed infections and> 1.2 million coronavirus related deaths, is one of the most …
[HTML][HTML] Beyond vaccines: clinical status of prospective COVID-19 therapeutics
S Kumar, DM Çalışkan, J Janowski, A Faist… - Frontiers in …, 2021 - frontiersin.org
Since November 2019 the SARS-CoV-2 pandemic has caused nearly 200 million infection
and more than 4 million deaths globally (Updated information from the World Health …
and more than 4 million deaths globally (Updated information from the World Health …
[HTML][HTML] After the hurricane: Anti-COVID-19 drugs development, molecular mechanisms of action and future perspectives
HO Khalifa, YM Al Ramahi - International Journal of Molecular Sciences, 2024 - mdpi.com
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a new coronavirus in
the Coronaviridae family. The COVID-19 pandemic, caused by SARS-CoV-2, has …
the Coronaviridae family. The COVID-19 pandemic, caused by SARS-CoV-2, has …
[HTML][HTML] Coronavirus disease 2019 (COVID-19): latest developments in potential treatments
KL Hon, KKY Leung, AKC Leung, SY Qian… - Drugs in …, 2020 - ncbi.nlm.nih.gov
Many viral respiratory infections can cause severe acute respiratory symptoms leading to
mortality and morbidity. In the spring of 2003, the severe acute respiratory syndrome (SARS) …
mortality and morbidity. In the spring of 2003, the severe acute respiratory syndrome (SARS) …